CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Bacterial vaginosis - Management
Basis for recommendation
Persistent symptoms
- CKS found no evidence regarding treatment options if initial treatment is unsuccessful. A pragmatic approach may be needed to ensure that the current episode is adequately managed.
Removal of intrauterine device (IUD)
- Bacterial vaginosis (BV) is more common in women with an IUD; the recommendation to consider IUD removal in a woman with persistent BV is pragmatic, supported by the opinion of CKS expert reviewers.
Not screening and treating male partners
- No reduction in relapse rate was reported from studies in which male partners of women with BV were treated with metronidazole, tinidazole, or clindamycin [BASHH, 2006].
© NHS Institute for Innovation and Improvement